.png)
Our Facility
OptMed’s skin protectants and adhesives are developed and manufactured with high-quality standards by its subsidiary, Synkotech Biocompatible Materials, located in Tarragona, Spain. The facility is ISO 13485:2016 certified.
Revolutionizing
Medical Adhesives and Skin Protectants
with
Industry-First
Methylidene
Malonate
"Zero Cyanoacrylates,
Zero Compromises"
OptMed is developing medical adhesives and skin protectants to address a broad spectrum of clinical indications
OptMed, Inc. is a privately held medical device company engaged in developing, manufacturing and commercializing a line of skin protectants and surgical adhesives for both topical and internal use, built on its proprietary methylidene malonate chemistry platform.
Our EpiPly®(US) and BlauProtect®(EU) brands of skin protectant are commercially available.
BondEase® Topical Skin Adhesive, OptMed’s first clinical indication, received 510(k) marketing clearance from FDA.
The FDA also granted 510(k) marketing clearance to TearRepair® as a skin protectant.
Our Products
Discover our entire range of methylidene malonate-based skin protectants.
.png)
Description
BondEase® Topical Skin Adhesive is a sterile, liquid topical skin closure device composed of a methylidene malonate monomer formulation and the colorant D&C Green #6. It is provided in a single-use applicator, packaged in a foil pouch. The applicator is comprised of a crushable glass ampoule contained within a plastic vial with attached applicator tip and handle.
BondEase® is applied to the skin as a viscous liquid which polymerizes to bond approximated wound edges within minutes. In vitro studies have shown that BondEase® acts as a bacterial barrier as long as the adhesive film remains intact.
Quick-drying
The film sets within 1-2 minutes after application.
Transparent and patient-friendly
Clean and dry the skin thoroughly before applying. Ensure all traces of moisturizers, lotions, and lotion soaps are removed from the application site.
Adheres to the skin
It is applied as a liquid and dries within minutes, adhering to the contours of the skin to form a transparent flexible film.
Disappears naturally
The film will wear off the skin naturally and does not require removal.
.png)
Description
TearRepair® Liquid Skin protectant is a non-cytotoxic, methylidene malonate based, rapid-drying liquid barrier film for the protection of the skin.
It is applied as a liquid and dries within minutes, adhering to the contours of the skin to form a transparent flexible film. TearRepair® will wear off, naturally, as the skin regenerates.
The film is transparent and possesses good oxygen and moisture vapor permeability.
The product is provided sterile.
Quick-drying
The film sets within 1-2 minutes after application.
Transparent and patient-friendly
Clean and dry the skin thoroughly before applying. Ensure all traces of moisturizers, lotions, and lotion soaps are removed from the application site.
Adheres to the skin
It is applied as a liquid and dries within minutes, adhering to the contours of the skin to form a transparent flexible film.
Disappears naturally
The film will wear off the skin naturally and does not require removal.
The EpiPly® line of skin protectants
.png)
.png)
.png)
Description
EpiPly® Skin Barrier Film is a non-cytotoxic, methylidene malonate based, rapid-drying barrier film for the protection of the skin.
It is applied as a film and dries within minutes, adhering to the contours of the skin to form a transparent flexible film. EpiPly® will wear off, naturally, as the skin regenerates.
The film is transparent and possesses good oxygen and moisture vapor permeability. The product is provided sterile.
Quick-drying
The film sets within 1-2 minutes after application.
Transparent and patient-friendly
Clean and dry the skin thoroughly before applying. Ensure all traces of moisturizers, lotions, and lotion soaps are removed from the application site.
Adheres to the skin
It is applied as a liquid and dries within minutes, adhering to the contours of the skin to form a transparent flexible film.
Disappears naturally
The film will wear off the skin naturally and does not require removal.
In Development
OptMed’s product pipeline leverages our proprietary Methylidene Malonate chemistry to develop, and design tailored medical soft tissue adhesives for applications outside and inside the body. Working closely with our expert medical advisors, OptMed is developing a range of disruptive products which address critical surgical unmet needs.
OptMed has dedicated its efforts to address multiple clinical areas which are in need of innovative products that tackle the unmet clinical needs of clinicians and patients alike. Those areas are:
Wounds which remain open for the body to close by secondary intent or through re-epithelialization. These wounds include chronic wounds (diabetic foot, venous leg, arterial and pressure ulcers) and surgical wounds left open to heal (burns, donor sites, Mohs surgery, staged surgical procedures, skin grafting, biopsies, etc.).
Closing of open wound with OptMed's methylidene malonate adhesive on ex-vivo human skin
Tissue adhesives for the management of open chronic and acute wounds
Surgical and/or traumatic wounds inside the body. These wounds require either an adhesive and/or a sealant to complete the procedure. They include, but are not limited to, internal incisions and subcutaneous layers, incisions, dissections, resections, dural repair and closing of dead space. Sealing of vessels, bowel, lung, bladder, seroma, hematoma, etc.
Incision in lamb heart sealed with OptMed's methylidene malonate adhesive
Tissue adhesives for the closure of internal wounds
Our Leadership Team
_edited.jpg)
Ervin Braun, DMD
Chief Executive Officer, Director
Mike Myers
President, Director
.png)
Alain Klapholz, MBA
Chief Technology Officer, Founder
_edited.jpg)
H.F. Burrows, MBA, EMT, CWCA, BCMAS
Chief Operating Officer
Verónica de la Fuente, PhD
VP of R&D and Manufacturing
Our Board of Directors
_edited.jpg)
Martin Sands
Ervin Braun, DMD
Steven Sands
Mike Myers
Meyer B. Stone
Ruiping Dong
.png)
Kenneth Burhop
.png)
James J. Chao
Our Medical Advisory Board
Thomas Davenport, MD, FACS
James Quinn, MD, MS
.png)